Ann: Departure of a Doctor, page-23

The sell recommendation was light on info and written in a pretty obtuse way. The implication was that the company might be hiding something - it seemed suggested that it was weird that this one doctor would cause an NPAT hit not in 2018 but 2019 - the recommendation concluded that there may be some other issue at play. If I was to be skeptical, the Barefoot stock picks lately have been pretty average, so given if you had bought upon their initial MVF buy listing you would be up 40%, they might just be trying to lock in some credible gains across their suite of recommendations.